Variables contributing to acute mountain sickness on the summit of Mt Whitney

Wilderness and Environmental Medicine

Volumn 17, Issue 4, 2006, Pages 221-228

  Wagner, Dale R ^a   Fargo, Jamison D ^a   Parker, Daryl ^b   Tatsugawa, Kevin ^c   Young, Troy A ^d  

^a UTAH STATE UNIVERSITY   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c NORTHERN ARIZONA UNIVERSITY   (United States)

^d Marysville Veterinary Hospital   (United States)

Author keywords

Altitude illness; Arterial oxygen saturation; Hypoxia; Mountaineering; Trekking

Indexed keywords

ACETAZOLAMIDE; ANALGESIC AGENT;

ADULT; AGE DISTRIBUTION; ALTITUDE DISEASE; ANALGESIA; ARTERIAL OXYGEN SATURATION; ARTICLE; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PULSE OXIMETER; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

EID: 33846275778     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/PR43-05.1     Document Type: Article

References (33)

1. Roach RC, Bärtsch P, Hackett PH, Oelz O (Lake Louise AMS Scoring Consensus Committee). The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and Molecular Medicine. Burlington, VT: Queen City Printers; 1993:272-274.
2. Hackett PH, Roach RC. High altitude illness. N Engl J Med. 2001;345:107-114.
3. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol. 2001;204:3161-3170.
4. Basnyat B, Lemaster J, Litch JA. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat Space Environ Med. 1999;70:867-873.
5. Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol. 2004;5:410-419.
6. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993;118:587-592.
7. Schneider M, Bernasch D, Weymann J, Holle R, Bärtsch P. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc. 2002; 34:1886-1891.
8. Ziaee V, Yunesian M, Ahmadinejad Z, et al. Acute mountain sickness in Iranian trekkers around Mount Damavand (5671 m) in Iran. Wilderness Environ Med. 2003;14:214-219.
9. Ward MP, Milledge JS, West JB. High Altitude Medicine and Physiology. London, UK: Arnold; 2000:215-231.
10. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 2000:92-104.
11. Bendel RB, Afifi AA. Comparison of stopping rules in forward regression. J Am Stat Assoc. 1977;72:46-53.
12. Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137.
13. Maggiorini M, Bühler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 1990; 301:853-855.
14. Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976;2:1149-1154.
15. Murdoch DR. Symptoms of infection and altitude illness among hikers in the Mount Everest region of Nepal. Aviat Space Environ Med. 1995;66:148-151.
16. Roach RC, Greene ER, Schoene RB, Hackett PH. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med. 1998;69:1182-1185.
17. Roach RC, Houston CS, Honigman B, et al. How well do older persons tolerate moderate altitude? West J Med. 1995;162:32-36.
18. Silber E, Sonnenberg P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PJ. Clinical features of headache at altitude: a prospective study. Neurology. 2003;60:1167-1171.
19. Ross RT. The random nature of cerebral mountain sickness. Lancet. 1985;1:990-991.
20. Bärtsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW. Acute mountain sickness: controversies and advances. High Alt Med Biol. 2004;5:110-124.
21. Graham J, Potyk D. Age and acute mountain sickness: examining the data. J Am Geriatr Soc. 2005;53:735.
22. Basnyat B, Subedi D, Sleggs J, et al. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ Med. 2000;11:89-93.
23. Ri-Li G, Chase PJ, Witkowski S, et al. Obesity: associations with acute mountain sickness. Ann Intern Med. 2003; 139:253-257.
24. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
25. Beidleman BA, Muza SR, Fulco CS, et al. Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Clin Sci (Lond). 2004;106:321-328.
26. Muza SR, Rock PB, Zupan MF, Miller JC, Thomas WR, Cymerman A. Residence at moderate altitude improves ventilatory response to high altitude. Aviat Space Environ Med. 2004;75:1042-1048.
27. Honigman B, Read M, Lezotte D, Roach RC. Sea-level physical activity and acute mountain sickness at moderate altitude. West J Med. 1995;163:117-121.
28. Cumbo TA, Basnyat B, Graham J, Lescano AG, Gambert S. Acute mountain sickness, dehydration, and bicarbonate clearance: preliminary field data from the Nepal Himalaya. Aviat Space Environ Med. 2002;73:898-901.
29. Loeppky JA, Icenogle MV, Maes D, Riboni K, Hinghofer-Szalkay H, Roach RC. Early fluid retention and severe acute mountain sickness. J Appl Physiol. 2005;98:591-597.
30. Westerterp KR, Robach P, Wouters L, Richalet JP. Water balance and acute mountain sickness before and after arrival at high altitude of 4350 m. J Appl Physiol. 1996;80: 1968-1972.
31. O'Connor T, Dubowitz G, Bickler PE. Pulse oximetry in the diagnosis of acute mountain sickness. High Alt Med Biol. 2004;5:341-348.
32. Larson EB, Roach RC, Schoene RB, Hornbein TF. Acute mountain sickness and acetazolamide. JAMA. 1982;248: 328-332.
33. Gertsch JH, Seto TB, Mor J, Onopa J. Gingko biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt Med Biol. 2002;3:29-37.